Yung-Bin Kuo
Chang Gung University
19 Papers
83 Citations
Yung-Bin Kuo is an academic researcher from Chang Gung University. The author has contributed to research in topics: Phospholipid scramblase & Autoantibody. The author has an hindex of 11, co-authored 19 publications. Previous affiliations of Yung-Bin Kuo include National Chiao Tung University.
Chat about Author
Papers
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.
TL;DR: In this paper, the presence of KRAS mutations in circulating cell-free DNA (cfDNA) and primary tumor tissue using a peptide nucleic acid mediated polymerase chain reaction was compared.
70
Multiple serological biomarkers for colorectal cancer detection
Chung-Chuan Chan,Chung-Wei Fan,Yung-Bin Kuo,Yung-Bin Kuo,Yu-Han Chen,Pi-Yueh Chang,Kuei-Tien Chen,Ray-Ping Hung,Err-Cheng Chan +8 more
TL;DR: Results collectively indicated that combined detection of serum autoantibody profiles against a panel of colorectal tumor‐associated antigens and the analysis of carcinoembryonic antigen provides a promising diagnostic biomarker for coloreCTal cancer, particularly among early‐stage patients.
58
Identification of Phospholipid Scramblase 1 as a Biomarker and Determination of Its Prognostic Value for Colorectal Cancer
Yung-Bin Kuo,Chung-Chuan Chan,C. Allen Chang,C. Allen Chang,Chung-Wei Fan,Ray-Ping Hung,Ya-Shu Hung,Kuei-Tien Chen,Jau-Song Yu,Yu-Sun Chang,Err-Cheng Chan +10 more
TL;DR: Examination of the expression of phospholipid scramblase 1 in tumor tissues and plasma specimens of patients with colorectal cancer and its association with clinical parameters revealed that elevated PLSCR1 expression indicated a poor prognosis for CRC, and the plasma levels were significantly elevated in patients with early stage CRC compared with healthy individuals.
51
Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
TL;DR: The results indicate that inflammation plays a crucial role in the pathogenesis process of oral cavity squamous cell carcinoma and by examining the inflammation markers, physicians could potentially identify patients at risk of cancer transformation or relapse.
50
Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo
Chung-Wei Fan,Chun-Yu Chen,Kuei-Tien Chen,Chia-Rui Shen,Yung-Bin Kuo,Ya-Shan Chen,Yeh-Pin Chou,Yeh-Pin Chou,Wei-Shan Wei,Err-Cheng Chan +9 more
TL;DR: Treating CRC cells with NP1 in vitro and in vivo decreased cell proliferation, anchorage-independent growth, migration, and invasion, and may serve as a potential therapeutic target for CRC.